Cover Image

Anti-angiogenic activity of VXM01, an oral T-cell vaccine against VEGF receptor 2, in patients with advanced pancreatic cancer: a randomized, placebo-controlled, phase 1 trial

Saved in:
Bibliographic Details
Main Authors: Schmitz-Winnenthal, Friedrich Hubertus (Author) , Hohmann, Nicolas (Author) , Friedrich, Tobias (Author) , Mikus, Gerd (Author) , Weitz, Jürgen (Author) , Ulrich, Alexis (Author) , Büchler, Markus W. (Author) , Pianka, Frank (Author) , Klaiber, Ulla (Author) , Diener, Markus K. (Author) , Leowardi-Bauer, Christine (Author) , Schimmack, Simon (Author) , Peters, Leila (Author) , Springfeld, Christoph (Author) , Knebel, Phillip (Author) , Schmidt, Thomas (Author) , Ge, Yingzi (Author) , Stamova, Slava (Author) , Podola, Lilli (Author) , Haefeli, Walter E. (Author) , Grenacher, Lars (Author) , Beckhove, Philipp (Author)
Format: Article (Journal)
Language:English
Published: 16 Mar 2015
In: OncoImmunology
Year: 2015, Volume: 4, Issue: 4
ISSN:2162-402X
DOI:10.1080/2162402X.2014.1001217
Online Access:Verlag, Volltext: http://dx.doi.org/10.1080/2162402X.2014.1001217
Get full text
Author Notes:Friedrich H. Schmitz-Winnenthal, Nicolas Hohmann, Andreas G. Niethammer, Tobias Friedrich, Heinz Lubenau, Marco Springer, Klaus M. Breiner, Gerd Mikus, Jürgen Weitz, Alexis Ulrich, Markus W. Büchler, Frank Pianka, Ulla Klaiber, Markus Diener, Christine Leowardi, Simon Schimmack, Leila Sisic, Anne-Valérie Keller, Ruhan Koc, Christoph Springfeld, Philipp Knebel, Thomas Schmidt, Yingzi Ge, Mariana Bucur, Slava Stamova, Lilli Podola, Walter E. Haefeli, Lars Grenacher and Philipp Beckhove
Description
Item Description:Gesehen am 01.12.2016
Physical Description:Online Resource
ISSN:2162-402X
DOI:10.1080/2162402X.2014.1001217

Similar Items